Oklahoma Psychedelic Legislation

6 psychedelic policy bills tracked in Oklahoma, covering Ibogaine, Psilocybin. Current status breakdown: Died (4), Signed into Law (1), In Committee (1).

Oklahoma psychedelic bills

Bill	State	Substance	Type	Status	Sponsor	Last action
HB3834 - Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; Office of the State Treasurer; adverse licensing action; effective date.	Oklahoma	Ibogaine	Clinical Research	Signed into Law	Stan May	May 12, 2026
HB4293 - Controlled dangerous substances; Veterans Mental Health Innovation Act; authorizing certain scientific research and clinical trials related to ibogaine; requiring registration; providing certain immunities; effective date.	Oklahoma	Ibogaine	Clinical Research	In Committee	Daniel Pae	Feb 10, 2026
HB2107 - Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.	Oklahoma	Psilocybin	Clinical Research	Died	Daniel Pae	Mar 29, 2023
HB2107 - Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.	Oklahoma	Psilocybin	Clinical Research	Died	Daniel Pae	Mar 29, 2023
HB3414 - Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.	Oklahoma	Psilocybin	Clinical Research	Died	Logan Phillips	Apr 14, 2022
HB3174 - Public health; providing for the establishment of statewide investigational new drug applications for psilocybin clinical trials; effective date.	Oklahoma	Psilocybin	Clinical Research	Died	Logan Phillips	Feb 8, 2022

All states · Full psychedelic legislation tracker